Lobbying Relationship

Client

The Livingston Group on behalf of Innovative Vaccine Technologies

More records

Lobbying firm

Magill Associates, LLC

More records

  • FY 2024 and FY 2025 appropriations for the development of a synthetic vaccine

Duration: to

General Issues: Budget/Appropriations, Medical/Disease Research/Clinical Labs

Spending: about $350,000 (But it's complicated. Here's why.)

Agencies lobbied since 2021: U.S. Senate, House of Representatives, Defense - Dept of (DOD), Army - Dept of (Other)

Affiliated organizations: Hexamer Therapeutics, Inc

Bills mentioned

H.R.2471: Consolidated Appropriations Act, 2022

Sponsor: Hakeem Jeffries (D-N.Y.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
John Magill COS to Rep Wally Herger
John Magill Magill COS to Rep. Wally Herger COS to Rep Wally Herger

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Amendment
Q2 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page